These findings documented a change in the dendritic cell compartment of the tumor tissue after m1928z-CD40L CAR T cell treatment, wherein m1928z-CD40L CAR T cells skew the tumor-resident cDC1/cDC2 ratio in favor of the cDC1 population (Fig. 1h and Supplementary Fig. 1C). This evidence concerns the gene CD40LG and neoplasm.